Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Seraprevir + Sofosbuvir in HCV Genotype 1
NCT04001608Phase 3Unknown
- Sponsor
- Ginkgo Bioworks
- Start
- Oct 2018
- Primary completion
- Jul 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of seraprevir in hepatitis C (HCV), sponsored by Ginkgo Bioworks. Status: unknown.
02
Drugs
seraprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT04001608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04001608.